医学信息
醫學信息
의학신식
MEDICAL INFORMATION
2014年
16期
602-602
,共1页
H1及H2受体阻滞剂%眩晕%疗效观察
H1及H2受體阻滯劑%眩暈%療效觀察
H1급H2수체조체제%현훈%료효관찰
H1 and H2 receptor antagonists%Vertigo%Ef ect observation
目的：观察H1及H2受体阻滞剂治疗眩晕的疗效。方法将195例眩晕患者分成对照组和治疗组。对照组以银杏达莫、胞二磷胆碱静滴，西比灵口服，治疗组在对照组基础上加用异丙嗪及法莫替丁静滴，比较两组治疗后眩晕症状改善状况。结果治疗2d后加用H1及H2受体阻滞剂（异丙嗪及法莫替丁）组患者眩晕治疗效果显著。
目的：觀察H1及H2受體阻滯劑治療眩暈的療效。方法將195例眩暈患者分成對照組和治療組。對照組以銀杏達莫、胞二燐膽堿靜滴，西比靈口服，治療組在對照組基礎上加用異丙嗪及法莫替丁靜滴，比較兩組治療後眩暈癥狀改善狀況。結果治療2d後加用H1及H2受體阻滯劑（異丙嗪及法莫替丁）組患者眩暈治療效果顯著。
목적：관찰H1급H2수체조체제치료현훈적료효。방법장195례현훈환자분성대조조화치료조。대조조이은행체막、포이린담감정적，서비령구복，치료조재대조조기출상가용이병진급법막체정정적，비교량조치료후현훈증상개선상황。결과치료2d후가용H1급H2수체조체제（이병진급법막체정）조환자현훈치료효과현저。
Objective We aimed to observe the ef ect of H1 and H2 receptor antagonists in treating vertigo patients.Methods 195 vertigo patients were divided into H1 and H2 receptor antagonist group and otherwise control group.The control group was treated with Gingo and CDP-C intravenous and sebelium oral y.The H1 and H2 receptor antagonist group was treated with phenergan (promethazine) muscularly and famotidine intravenously.We compare the change of vertigo symptoms after both treatment regimens in two days.Results The H1 and H2 receptor antagonist group has bet er ef ect on control ing vertigo symptoms.
